Arvest Trust’s Merck MRK Stock Holding History

Arvest Trust’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$3.43M	Sell	27,672 -2,916	-10%	-$376K	0.2%	62
2024 Q1	$4.04M	Sell	30,588 -3,027	-9%	-$373K	0.23%	63
2023 Q4	$3.66M	Sell	33,615 -2,587	-7%	-$269K	0.22%	64
2023 Q3	$3.73M	Buy	36,202 +805	+2%	+$86.8K	0.24%	63
2023 Q2	$3.78M	Buy	35,397 +827	+2%	+$93.9K	0.22%	63
2023 Q1	$3.68M	Sell	34,570 -6,599	-16%	-$712K	0.23%	64
2022 Q4	$4.57M	Buy	41,169 +3,261	+9%	+$333K	0.29%	61
2022 Q3	$3.27M	Buy	37,908 +12,912	+52%	+$1.15M	0.22%	64
2022 Q2	$2.28M	Buy	24,996 +4,544	+22%	+$403K	0.15%	67
2022 Q1	$1.68M	Buy	20,452 +3,264	+19%	+$257K	0.09%	74
2021 Q4	$1.32M	Buy	+17,188	New	+$1.37M	0.07%	76
2014 Q2	$204K	Hold	3,702	–	–	0.02%	114
2014 Q1	$207K	Buy	+3,702	New	+$192K	0.02%	109

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Arvest Trust's MRK Position: Q2 2024 in Review

Arvest Trust reduced its Merck (MRK) stake by 9.5% in Q2 2024, selling an estimated $376K and leaving 27,672 shares worth $3.43M. The position accounts for 0.2% of the portfolio, ranked #62.

Arvest Trust first reported a position in MRK in Q1 2014 and has held it in 13 quarters since. The position peaked at $4.57M in Q4 2022. 3,545 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

Arvest Trust held 27,672 shares of Merck worth $3.43M as of Q2 2024.
Arvest Trust sold 2,916 Merck shares in Q2 2024, an estimated $376K.
Merck made up 0.2% of Arvest Trust's portfolio in Q2 2024, its #62 holding.
Arvest Trust first reported a position in Merck in Q1 2014 and has held it in 13 quarters since.
Arvest Trust's Merck position peaked at $4.57M in Q4 2022.
3,545 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Arvest Trust's 13F filing for Q2 2024, filed 9 Aug 2024.